Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This study is a collaboration between the University of Pennsylvania, the Philadelphia Prison
System, and the North East Treatment Center (NETSteps). It purpose is to study the impact of
an injectable opiate addiction medication (extended release naltrexone) given before reentry
into the community that might help to improve reconnection to healthcare and other support
systems, and possibly help reduce recidivism.